479-37-8 (16H-1,24:6,9-二苯-11,15-甲基-2H-吡啶并[2',3':17,18][1,11]二氧酰基氯代[2,3,4-ij]异喹啉-12,22-二醇,3,4,4a,5,16a,17,18,19-八氢-21,26-二甲氧基-4,17-二甲基-(4aS,16aR)-(9CI),16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline-12,22-diol,3,4,4a,5,16a,17,18,19-octahydro-21,26-dimethoxy-4,17-dimethyl-, (4aS,16aR)-(9CI))

CAS号:
479-37-8
中文名称:
16H-1,24:6,9-二苯-11,15-甲基-2H-吡啶并[2',3':17,18][1,11]二氧酰基氯代[2,3,4-ij]异喹啉-12,22-二醇,3,4,4a,5,16a,17,18,19-八氢-21,26-二甲氧基-4,17-二甲基-(4aS,16aR)-(9CI)
英文名称:
16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline-12,22-diol,3,4,4a,5,16a,17,18,19-octahydro-21,26-dimethoxy-4,17-dimethyl-, (4aS,16aR)-(9CI)
分子式:
C36H38N2O6
分子量:
594.696730136871

16H-1,24:6,9-二苯-11,15-甲基-2H-吡啶并[2',3':17,18][1,11]二氧酰基氯代[2,3,4-ij]异喹啉-12,22-二醇,3,4,4a,5,16a,17,18,19-八氢-21,26-二甲氧基-4,17-二甲基-(4aS,16aR)-(9CI)(479-37-8)名称与标识符

名称

英文别名:
16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline-12,22-diol,3,4,4a,5,16a,17,18,19-octahydro-21,26-dimethoxy-4,17-dimethyl-, (4aS,16aR)-(9CI);(+)-Obamegine;16H-1,24:6,9-Dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline-12,22-diol,3,4,4a,5,;obamegine;6,6'-Dimethoxy-2,2'-dimethyl-berbaman-7,12-diol;6,6'-dimethoxy-2,2'-dimethyl-berbamane-7,12-diol;NSC-251534;(4aS,16aR)-3,4,4a,5,16a,17,18,19-Octahydro-21,26-dimethoxy-4,17-dimethyl-16H-1,24:6,9-dietheno-11,15-metheno-2H-pyrido[2',3':17,18][1,11]dioxacycloeicosino[2,3,4-ij]isoquinoline-12,22-diol;Berbaman-7,12-diol, 6,6'-dimethoxy-2,2'-dimethyl-;CHEBI:7714;Obamegin;CHEMBL452895;Q27107564;UNII-75K1EI2HDP;OBAMEGINE, (+)-;DTXSID301098623;15,30-Diaza-20,25-dimethoxy-15,30-dimethyl-7,23-dioxaheptacyclo[22.6.2.2<3,6>.1<8,12>.1<14,18>.0<22,36>.0<27,31>]hexatriaconta-3(33),4,6(34),8,10,12(35),18(36),19,21,24,26,31-dodecaene-9,21-diol;Stepholine;16H-1,24:6,9-DIETHENO-11,15-METHENO-2H-PYRIDO(2',3':17,18)(1,11)DIOXACYCLOEICOSINO(2,3,4-IJ)ISOQUINOLINE-12,22-DIOL, 3,4,4A,5,16A,17,18,19-OCTAHYDRO-21,26-DIMETHOXY-4,17-DIMETHYL-, (4AS,16AR)-;16H-1,24:6,9-DIETHENO-11,15-METHENO-2H-PYRIDO(2',3':17,18)(1,11)DIOXACYCLOEICOSINO(2,3,4-IJ)ISOQUINOLINE-12,22-DIOL, 3,4,4A,5,16A,17,18,19-OCTAHYDRO-21,26-DIMETHOXY-4,17-DIMETHYL-, (4AS-(4AR*,16AS*))-;479-37-8;NSC-123123;75K1EI2HDP;C06513;NSC 123123;BDBM50508726;NS00094122;Obamogenine;NSC123123;CHEMBL492604;(+)-N-Methyl-7-O-demethylpeinamine;(-)-Krukovine;1'-Epiatherospermoline;(+)-Atherospermoline;

标识符

InChIKey:
XGEAUXVPBXUBKN-WUFINQPMSA-N
Inchi:
1S/C36H38N2O6/c1-37-13-11-23-18-31(41-3)32-20-26(23)27(37)15-21-5-8-25(9-6-21)43-30-17-22(7-10-29(30)39)16-28-34-24(12-14-38(28)2)19-33(42-4)35(40)36(34)44-32/h5-10,17-20,27-28,39-40H,11-16H2,1-4H3/t27-,28+/m0/s1
SMILES:
O1C2C(=CC3CCN(C)[C@@H](CC4C=CC(=CC=4)OC4C(=CC=C(C=4)C[C@@H]4C5C1=C(C(=CC=5CCN4C)OC)O)O)C=3C=2)OC

16H-1,24:6,9-二苯-11,15-甲基-2H-吡啶并[2',3':17,18][1,11]二氧酰基氯代[2,3,4-ij]异喹啉-12,22-二醇,3,4,4a,5,16a,17,18,19-八氢-21,26-二甲氧基-4,17-二甲基-(4aS,16aR)-(9CI)(479-37-8)物化性质

实验特性

  • LogP : 6.43220
  • PSA : 83.86000
  • 折射率 : 1.619
  • 沸点 : 706.5°Cat760mmHg
  • 闪点 : 381.1°C
  • 密度 : 1.239

计算特性

  • 精确分子量 : 594.27300
  • 氢键供体数量 : 2
  • 氢键受体数量 : 8
  • 可旋转化学键数量 : 2
  • 同位素质量 : 594.273
  • 重原子数量 : 44
  • 复杂度 : 948
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 2
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 5.7
  • 拓扑分子极性表面积 : 83.9Ų

16H-1,24:6,9-二苯-11,15-甲基-2H-吡啶并[2',3':17,18][1,11]二氧酰基氯代[2,3,4-ij]异喹啉-12,22-二醇,3,4,4a,5,16a,17,18,19-八氢-21,26-二甲氧基-4,17-二甲基-(4aS,16aR)-(9CI)(479-37-8)相关文献